risedronic acid has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SJ; Ji, JD; Kim, S; Lee, YH; Song, GG; Woo, JH | 1 |
| Blake, GM; Eastell, R; Fogelman, I; Frost, ML; Marsden, PK; Moore, AE; Schleyer, PJ; Siddique, M | 1 |
1 trial(s) available for risedronic acid and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Etidronic Acid; Female; Femur; Fluorodeoxyglucose F18; Hip; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Positron-Emission Tomography; Radiopharmaceuticals; Risedronic Acid; Treatment Outcome | 2012 |
1 other study(ies) available for risedronic acid and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.
Topics: Asymptomatic Diseases; Bone Density Conservation Agents; Diagnosis, Differential; Etidronic Acid; Female; Fluorodeoxyglucose F18; Humans; Ilium; Incidental Findings; Middle Aged; Osteitis Deformans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risedronic Acid; Sclerosis; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |